SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-16-124804
Filing Date
2016-06-01
Accepted
2016-06-01 18:54:27
Documents
2
Period of Report
2016-06-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 15437
2 POA DOCUMENT poa.txt EX-24.3_658948 3957
  Complete submission text file 0001209191-16-124804.txt   20807
Mailing Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005
Business Address 1220 OLD ALPHARETTA RD SUITE 300 ALPHARETTA GA 30005 678-270-4005
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O HATTERAS VENTURE PARTNERS III, LP 280 S. MANGUM ST., SUITE 350 DURHAM NC 27701
Business Address
Thorp Clay (Reporting) CIK: 0001592380 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37783 | Film No.: 161690554